Red or Gold (SST) 2 tubes total
Lavender (EDTA) 3 tubes total
Light blue (sodium citrate) 7 tubes total OR 11 - 0.5 ml aliquots of platelet poor plasma
All tests perfomed from Sodium Citrate tubes must be performed by the lab within 4 hours of collection. If transport delayed prepare platelet poor plasma for the sodium citrate tubes.
To produce platelet poor citrated plasma. Specimens should not become warm during centrifugation.
Centrifuge: 1500-2000 Gs. For 20 minutes. The centrifugation time and speed must be determined for each centrifuge. Platelet count on the platelet poor citrated plasma must be <10,000/uL. Double centrifugation is needed for slower centrifuges. Inspect each tube for hemolysis or lipemia. Do not use sticks to check for clots until the plasma has been removed. With plastic transfer pipette, remove 3/4 of the plasma. Do not disturb the plasma near the red cells. Pipet from the top of the plasma portion. Place plasma into plastic tubes. Examine remaining cells for for clots. Cap and freeze the plasma immediately. Label the tube with patient name and indicate 'platelet poor citrated plasma'. Mimimum of 0.5 mL per aliquot. Two aliquots per coagulation assay should be sufficient. Refer to individual test listing. Double centrifugation for slower centrifuges: Recentrifuge the plasma from the first centrifugation for 20 minutes. Remove the top 3/4 of plasma and place into plastic tube with cap. Perform platelet count, if possible. Repeat step until platelet count is <10,000 /uL. Cap and freeze the plasma immediately. Label the tube with patient name and indicate 'platelet poor citrated plasma'. Mimimum of 0.5 mL per aliquot. Two aliquots per coagulation assay should be sufficient. Refer to individual test listing.
All tests perfomed from Sodium Citrate tubes must be performed by the lab within 4 hours of collection. If transport delayed prepare platelet poor plasma for the sodium citrate tubes.
Sodium Citrate, platelet poor plasma (from light blue tube) should be frozen
This Panel includes:
See individual tests
Results in 5 days.
Interpretation and reference ranges included with report.
83090, 85610, 85730, 85613 x2, 85520, 85670, 85732 x2, 86147 X2, 85303, 85306, 85300, 85384, 85379, 85025, 81240, 81241 |
OrderCode | OrderName | ResultCode | ResultName | ResultUnits | RESULT LOINC | CPT |
HYPCGP | HYPERCOAGULABLE PANEL | BHCYS | HOMOCYSTEINE/BLOOD | umol/L | 13965-9 | 83090, 85610, 85730, 85613 x2, 85520, 85670, 85732 x2, 86147 X2, 85303, 85306, 85300, 85384, 85379, 85025, 81240, 81241 |
HYPCGP | HYPERCOAGULABLE PANEL | PTS | PROTIME (SECONDS) | sec | 5902-2 | |
HYPCGP | HYPERCOAGULABLE PANEL | INR | INTER NORMAL RATIO | 6301-6 | ||
HYPCGP | HYPERCOAGULABLE PANEL | PTTS | PTT | sec | 14979-9 | |
HYPCGP | HYPERCOAGULABLE PANEL | LATTIM | THROMBIN TIME | sec | 3243-3 | |
HYPCGP | HYPERCOAGULABLE PANEL | DSCRR | DRVVT Screen Ratio | |||
HYPCGP | HYPERCOAGULABLE PANEL | DCTR | DRVVT Screen/Confirm Ratio | |||
HYPCGP | HYPERCOAGULABLE PANEL | DMIXR | DRVVT Screen Mix Ratio | |||
HYPCGP | HYPERCOAGULABLE PANEL | DSCMR | DRVVT Screen Mix/Confirm Mix | |||
HYPCGP | HYPERCOAGULABLE PANEL | SSCRR | SCT Screen Ratio | |||
HYPCGP | HYPERCOAGULABLE PANEL | SCTR | SCT Screen/Confirm Ratio | |||
HYPCGP | HYPERCOAGULABLE PANEL | SMIXR | SCT Screen Mix/Confirm Mix | |||
HYPCGP | HYPERCOAGULABLE PANEL | SSCMR | SCT Screen Mix/Confirm Mix | |||
HYPCGP | HYPERCOAGULABLE PANEL | HEPQT | HEPARIN QUANT ASSAY | IU/mL | 42679-1 | |
HYPCGP | HYPERCOAGULABLE PANEL | INTP | LUPUS INTERPRETATION | |||
HYPCGP | HYPERCOAGULABLE PANEL | ACABG | CARDIOLIPIN AB, IgG | GPL U/mL | 3181-5 | |
HYPCGP | HYPERCOAGULABLE PANEL | ACABM | CARDIOLIPIN AB, IgM | MPL U/mL | 3182-3 | |
HYPCGP | HYPERCOAGULABLE PANEL | CACT | PROTEIN C ACTIVITY | % | 27819-2 | |
HYPCGP | HYPERCOAGULABLE PANEL | SACT | PROTEIN S FUNCTIONAL | % | 27822-6 | |
HYPCGP | HYPERCOAGULABLE PANEL | AT3 | ANTI-THROMBIN III | % | 27811-9 | |
HYPCGP | HYPERCOAGULABLE PANEL | FIBR | FIBRINOGEN | mg/dL | 3255-7 | |
HYPCGP | HYPERCOAGULABLE PANEL | WBC | WBC COUNT | X10E3/uL | 33256-9 | |
HYPCGP | HYPERCOAGULABLE PANEL | RBC | RBC COUNT | X10E6/uL | 789-8 | |
HYPCGP | HYPERCOAGULABLE PANEL | HGB | HEMOGLOBIN | g/dL | 718-7 | |
HYPCGP | HYPERCOAGULABLE PANEL | HCT | HEMATOCRIT | % | 4544-3 | |
HYPCGP | HYPERCOAGULABLE PANEL | MCV | MCV | fL | 787-2 | |
HYPCGP | HYPERCOAGULABLE PANEL | MCHC | MCHC | % | 786-4 | |
HYPCGP | HYPERCOAGULABLE PANEL | RDW | RBC DISTRIB WIDTH | % | 788-0 | |
HYPCGP | HYPERCOAGULABLE PANEL | PLTC | PLATELET COUNT | X10E3/uL | 777-3 | |
HYPCGP | HYPERCOAGULABLE PANEL | TDIF | TYPE OF DIFF DONE | 49024-3 | ||
HYPCGP | HYPERCOAGULABLE PANEL | ANEUT | AUTO ABS NEUT COUNT | X10E3/uL | 751-8 | |
HYPCGP | HYPERCOAGULABLE PANEL | NRBCRE | NUCLEATED RBCs | 19048-8 | ||
HYPCGP | HYPERCOAGULABLE PANEL | NEUT | NEUTROPHIL | % | 770-8 | |
HYPCGP | HYPERCOAGULABLE PANEL | LYMP | LYMPHOCYTE | % | 26478-8 | |
HYPCGP | HYPERCOAGULABLE PANEL | MONO | MONOCYTE | % | 26485-3 | |
HYPCGP | HYPERCOAGULABLE PANEL | EOS | EOSINOPHIL | % | 26450-7 | |
HYPCGP | HYPERCOAGULABLE PANEL | BASO | BASOPHIL | % | 30180-4 | |
HYPCGP | HYPERCOAGULABLE PANEL | IG | IMM GRANULOCYTES | % | ||
HYPCGP | HYPERCOAGULABLE PANEL | ALYM | ABSOLUTE LYMPHOCYTE | X10E3/uL | 731-0 | |
HYPCGP | HYPERCOAGULABLE PANEL | AMON | ABSOLUTE MONOCYTE | X10E3/uL | 742-7 | |
HYPCGP | HYPERCOAGULABLE PANEL | AEOS | ABSOLUTE EOS | X10E3/uL | 711-2 | |
HYPCGP | HYPERCOAGULABLE PANEL | ABAS | ABSOLUTE BASO | X10E3/uL | 704-7 | |
HYPCGP | HYPERCOAGULABLE PANEL | AIG | ABS IMM GRANULOCYTES | X10E3/uL | 51584-1 | |
HYPCGP | HYPERCOAGULABLE PANEL | PROTH | PROTHROMBIN FACT II | |||
HYPCGP | HYPERCOAGULABLE PANEL | LEYDN | LEIDEN FACTOR V | 21667-1 | ||
HYPCGP | HYPERCOAGULABLE PANEL | DIMER | D-DIMER | ng/mL FEU | 48065-7 | |
HYPCGP | HYPERCOAGULABLE PANEL | HINTRP | HYPERCOAGULABLE INTP | |||
Reflexes: | ||||||
If PTS is elevated: | ||||||
OrderCode | OrderName | ResultCode | ResultName | ResultUnits | RESULT LOINC | CPT |
LPTMX | LUPUS PT MIXING STDY | PTMXI | PT 1:1 MIX IMMED | sec | 5959-2 | 85611 |
If LATTIM is elevated | ||||||
OrderCode | OrderName | ResultCode | ResultName | ResultUnits | RESULT LOINC | CPT |
TTHEPZ | THROMB TIME HEP NEUT | TTHEPZ | THROMB TIME HEP NEUT | sec | 85670 | |
If PTTS is elevated: | ||||||
OrderCode | OrderName | ResultCode | ResultName | ResultUnits | RESULT LOINC | CPT |
PTTMXL | LUPUS PTT 1:1 IMMEDIATE MIXING STUDY | PTTMI | PTT 1:1 MIX IMMED | sec | 5946-9 | 85732 |
HEPNP | HEPARIN NEUTRALIZATN | HEPNP | HEPARIN NEUTRALIZATN | sec | 52123-7 | 85525 |
Collection |
Red or Gold (SST) 2 tubes total
Lavender (EDTA) 3 tubes total
Light blue (sodium citrate) 7 tubes total OR 11 - 0.5 ml aliquots of platelet poor plasma
All tests perfomed from Sodium Citrate tubes must be performed by the lab within 4 hours of collection. If transport delayed prepare platelet poor plasma for the sodium citrate tubes.
To produce platelet poor citrated plasma. Specimens should not become warm during centrifugation.
Centrifuge: 1500-2000 Gs. For 20 minutes. The centrifugation time and speed must be determined for each centrifuge. Platelet count on the platelet poor citrated plasma must be <10,000/uL. Double centrifugation is needed for slower centrifuges. Inspect each tube for hemolysis or lipemia. Do not use sticks to check for clots until the plasma has been removed. With plastic transfer pipette, remove 3/4 of the plasma. Do not disturb the plasma near the red cells. Pipet from the top of the plasma portion. Place plasma into plastic tubes. Examine remaining cells for for clots. Cap and freeze the plasma immediately. Label the tube with patient name and indicate 'platelet poor citrated plasma'. Mimimum of 0.5 mL per aliquot. Two aliquots per coagulation assay should be sufficient. Refer to individual test listing. Double centrifugation for slower centrifuges: Recentrifuge the plasma from the first centrifugation for 20 minutes. Remove the top 3/4 of plasma and place into plastic tube with cap. Perform platelet count, if possible. Repeat step until platelet count is <10,000 /uL. Cap and freeze the plasma immediately. Label the tube with patient name and indicate 'platelet poor citrated plasma'. Mimimum of 0.5 mL per aliquot. Two aliquots per coagulation assay should be sufficient. Refer to individual test listing.
All tests perfomed from Sodium Citrate tubes must be performed by the lab within 4 hours of collection. If transport delayed prepare platelet poor plasma for the sodium citrate tubes.
Sodium Citrate, platelet poor plasma (from light blue tube) should be frozen
This Panel includes:
Ordering |
See individual tests
Results in 5 days.
Result Interpretation |
Interpretation and reference ranges included with report.
Administrative |
83090, 85610, 85730, 85613 x2, 85520, 85670, 85732 x2, 86147 X2, 85303, 85306, 85300, 85384, 85379, 85025, 81240, 81241 |
RPS Interface Information |
OrderCode | OrderName | ResultCode | ResultName | ResultUnits | RESULT LOINC | CPT |
HYPCGP | HYPERCOAGULABLE PANEL | BHCYS | HOMOCYSTEINE/BLOOD | umol/L | 13965-9 | 83090, 85610, 85730, 85613 x2, 85520, 85670, 85732 x2, 86147 X2, 85303, 85306, 85300, 85384, 85379, 85025, 81240, 81241 |
HYPCGP | HYPERCOAGULABLE PANEL | PTS | PROTIME (SECONDS) | sec | 5902-2 | |
HYPCGP | HYPERCOAGULABLE PANEL | INR | INTER NORMAL RATIO | 6301-6 | ||
HYPCGP | HYPERCOAGULABLE PANEL | PTTS | PTT | sec | 14979-9 | |
HYPCGP | HYPERCOAGULABLE PANEL | LATTIM | THROMBIN TIME | sec | 3243-3 | |
HYPCGP | HYPERCOAGULABLE PANEL | DSCRR | DRVVT Screen Ratio | |||
HYPCGP | HYPERCOAGULABLE PANEL | DCTR | DRVVT Screen/Confirm Ratio | |||
HYPCGP | HYPERCOAGULABLE PANEL | DMIXR | DRVVT Screen Mix Ratio | |||
HYPCGP | HYPERCOAGULABLE PANEL | DSCMR | DRVVT Screen Mix/Confirm Mix | |||
HYPCGP | HYPERCOAGULABLE PANEL | SSCRR | SCT Screen Ratio | |||
HYPCGP | HYPERCOAGULABLE PANEL | SCTR | SCT Screen/Confirm Ratio | |||
HYPCGP | HYPERCOAGULABLE PANEL | SMIXR | SCT Screen Mix/Confirm Mix | |||
HYPCGP | HYPERCOAGULABLE PANEL | SSCMR | SCT Screen Mix/Confirm Mix | |||
HYPCGP | HYPERCOAGULABLE PANEL | HEPQT | HEPARIN QUANT ASSAY | IU/mL | 42679-1 | |
HYPCGP | HYPERCOAGULABLE PANEL | INTP | LUPUS INTERPRETATION | |||
HYPCGP | HYPERCOAGULABLE PANEL | ACABG | CARDIOLIPIN AB, IgG | GPL U/mL | 3181-5 | |
HYPCGP | HYPERCOAGULABLE PANEL | ACABM | CARDIOLIPIN AB, IgM | MPL U/mL | 3182-3 | |
HYPCGP | HYPERCOAGULABLE PANEL | CACT | PROTEIN C ACTIVITY | % | 27819-2 | |
HYPCGP | HYPERCOAGULABLE PANEL | SACT | PROTEIN S FUNCTIONAL | % | 27822-6 | |
HYPCGP | HYPERCOAGULABLE PANEL | AT3 | ANTI-THROMBIN III | % | 27811-9 | |
HYPCGP | HYPERCOAGULABLE PANEL | FIBR | FIBRINOGEN | mg/dL | 3255-7 | |
HYPCGP | HYPERCOAGULABLE PANEL | WBC | WBC COUNT | X10E3/uL | 33256-9 | |
HYPCGP | HYPERCOAGULABLE PANEL | RBC | RBC COUNT | X10E6/uL | 789-8 | |
HYPCGP | HYPERCOAGULABLE PANEL | HGB | HEMOGLOBIN | g/dL | 718-7 | |
HYPCGP | HYPERCOAGULABLE PANEL | HCT | HEMATOCRIT | % | 4544-3 | |
HYPCGP | HYPERCOAGULABLE PANEL | MCV | MCV | fL | 787-2 | |
HYPCGP | HYPERCOAGULABLE PANEL | MCHC | MCHC | % | 786-4 | |
HYPCGP | HYPERCOAGULABLE PANEL | RDW | RBC DISTRIB WIDTH | % | 788-0 | |
HYPCGP | HYPERCOAGULABLE PANEL | PLTC | PLATELET COUNT | X10E3/uL | 777-3 | |
HYPCGP | HYPERCOAGULABLE PANEL | TDIF | TYPE OF DIFF DONE | 49024-3 | ||
HYPCGP | HYPERCOAGULABLE PANEL | ANEUT | AUTO ABS NEUT COUNT | X10E3/uL | 751-8 | |
HYPCGP | HYPERCOAGULABLE PANEL | NRBCRE | NUCLEATED RBCs | 19048-8 | ||
HYPCGP | HYPERCOAGULABLE PANEL | NEUT | NEUTROPHIL | % | 770-8 | |
HYPCGP | HYPERCOAGULABLE PANEL | LYMP | LYMPHOCYTE | % | 26478-8 | |
HYPCGP | HYPERCOAGULABLE PANEL | MONO | MONOCYTE | % | 26485-3 | |
HYPCGP | HYPERCOAGULABLE PANEL | EOS | EOSINOPHIL | % | 26450-7 | |
HYPCGP | HYPERCOAGULABLE PANEL | BASO | BASOPHIL | % | 30180-4 | |
HYPCGP | HYPERCOAGULABLE PANEL | IG | IMM GRANULOCYTES | % | ||
HYPCGP | HYPERCOAGULABLE PANEL | ALYM | ABSOLUTE LYMPHOCYTE | X10E3/uL | 731-0 | |
HYPCGP | HYPERCOAGULABLE PANEL | AMON | ABSOLUTE MONOCYTE | X10E3/uL | 742-7 | |
HYPCGP | HYPERCOAGULABLE PANEL | AEOS | ABSOLUTE EOS | X10E3/uL | 711-2 | |
HYPCGP | HYPERCOAGULABLE PANEL | ABAS | ABSOLUTE BASO | X10E3/uL | 704-7 | |
HYPCGP | HYPERCOAGULABLE PANEL | AIG | ABS IMM GRANULOCYTES | X10E3/uL | 51584-1 | |
HYPCGP | HYPERCOAGULABLE PANEL | PROTH | PROTHROMBIN FACT II | |||
HYPCGP | HYPERCOAGULABLE PANEL | LEYDN | LEIDEN FACTOR V | 21667-1 | ||
HYPCGP | HYPERCOAGULABLE PANEL | DIMER | D-DIMER | ng/mL FEU | 48065-7 | |
HYPCGP | HYPERCOAGULABLE PANEL | HINTRP | HYPERCOAGULABLE INTP | |||
Reflexes: | ||||||
If PTS is elevated: | ||||||
OrderCode | OrderName | ResultCode | ResultName | ResultUnits | RESULT LOINC | CPT |
LPTMX | LUPUS PT MIXING STDY | PTMXI | PT 1:1 MIX IMMED | sec | 5959-2 | 85611 |
If LATTIM is elevated | ||||||
OrderCode | OrderName | ResultCode | ResultName | ResultUnits | RESULT LOINC | CPT |
TTHEPZ | THROMB TIME HEP NEUT | TTHEPZ | THROMB TIME HEP NEUT | sec | 85670 | |
If PTTS is elevated: | ||||||
OrderCode | OrderName | ResultCode | ResultName | ResultUnits | RESULT LOINC | CPT |
PTTMXL | LUPUS PTT 1:1 IMMEDIATE MIXING STUDY | PTTMI | PTT 1:1 MIX IMMED | sec | 5946-9 | 85732 |
HEPNP | HEPARIN NEUTRALIZATN | HEPNP | HEPARIN NEUTRALIZATN | sec | 52123-7 | 85525 |